The NYU Kaplan Comprehensive Cancer Center is an interdisciplinary and interdepartmental program designed to foster, enhance and coordinate the conduct of oncology research, education and patient care activity at NYU Medical Center. Gaining comprehensive status in 1991 and merging with the cancer center of the Institute of Environmental Medicine in 1992, the Center now represents the total spectrum of the institution's cancer activities. Its membership consists of NYU medical school faculty actively engaged in cancer research at all levels of investigation. The Center promotes through its program orientation and specialized shared resource units, the collaboration and technology transfer intended to more rapidly translate the benefits of research into more effective approaches to cancer. A broad range of oncology research is being conducted at the Center through nine program units and the support of seventeen shared resources. The Center places particular emphasis on elucidating the molecular and genetic events responsible for cellular transformation; the host defense mechanisms which regulate the immune response; the etiologic agents within the environment which cause or contribute to cancer; and the therapies and prevention which will prove to be more effective.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016087-17
Application #
2086436
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1975-06-30
Project End
1995-11-30
Budget Start
1994-02-15
Budget End
1994-11-30
Support Year
17
Fiscal Year
1994
Total Cost
Indirect Cost
Name
New York University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10016
Gagner, Jean-Pierre; Zagzag, David (2018) Probing Glioblastoma Tissue Heterogeneity with Laser Capture Microdissection. Methods Mol Biol 1741:209-220
Xu, Yang; Taylor, Paul; Andrade, Joshua et al. (2018) Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma. Cancer Res 78:6539-6548
Martin, Patricia K; Marchiando, Amanda; Xu, Ruliang et al. (2018) Autophagy proteins suppress protective type I interferon signalling in response to the murine gut microbiota. Nat Microbiol 3:1131-1141
Tsay, Jun-Chieh J; Wu, Benjamin G; Badri, Michelle H et al. (2018) Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer. Am J Respir Crit Care Med 198:1188-1198
Coux, Rémi-Xavier; Teixeira, Felipe Karam; Lehmann, Ruth (2018) L(3)mbt and the LINT complex safeguard cellular identity in the Drosophila ovary. Development 145:
de la Parra, Columba; Ernlund, Amanda; Alard, Amandine et al. (2018) A widespread alternate form of cap-dependent mRNA translation initiation. Nat Commun 9:3068
Fanok, Melania H; Sun, Amy; Fogli, Laura K et al. (2018) Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. J Invest Dermatol 138:1116-1125
Patibandla, Jay R; Fehniger, Julia E; Levine, Douglas A et al. (2018) Small cell cancers of the female genital tract: Molecular and clinical aspects. Gynecol Oncol 149:420-427
Harper, Lamia; Balasubramanian, Divya; Ohneck, Elizabeth A et al. (2018) Staphylococcus aureus Responds to the Central Metabolite Pyruvate To Regulate Virulence. MBio 9:
Berger, Ashton C; Korkut, Anil; Kanchi, Rupa S et al. (2018) A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. Cancer Cell 33:690-705.e9

Showing the most recent 10 out of 1170 publications